Solution Found for Mislabeled Specimens in Clinical Laboratories
|
By LabMedica International staff writers Posted on 30 Apr 2014 |

Image: An automated camera system developed for photographing specimen tube exteriors for vision processing and optical character recognition analysis to detect possible mislabeled specimens (Photo courtesy of ARUP laboratories).
The incidence of patient identification errors, including mislabeled and misidentified specimens, is thought to be unacceptably high in clinical laboratories.
The best data on errors in USA laboratories is derived from three separate College of American Pathologists (CAP; Northfield, IL, USA) Q-Probe studies, in which the reported rates of mislabeled specimens were 0.39/1,000 in 120 institutions in 2006, 0.92/1,000 in 147 clinical laboratories in 2008, and 1.12% of blood bank specimens in 122 clinical laboratories.
Laboratory scientists at the ARUP Laboratories (Salt Lake City, UT, USA) have examined the problem of misidentification and have suggested some possible solutions. One approach is the single piece flow and this concept has significant error-proofing potential for labeling tasks at relatively low cost. They suggest that to prevent errors during collection and processing, avoid having specimens from multiple patients in the active work area at the same time. Similarly, avoid using strips of labels from a label printer with labels for multiple patients that must be matched to specimens and if using an automated aliquoting device, be sure that the label exactly duplicates the barcode label from the primary tube to facilitate error detection.
Another tool that more laboratories are using is the portable barcode scanner. These scanners read wristband barcodes at point-of-collection and work well in conjunction with portable barcode label printers or point-of-care analytical devices. However, barcode devices make more errors than commonly believed. Display and layout inconsistency of the barcode can also leads to an increase in errors. It is recommended to implement the Clinical and Laboratory Standards Institute (Wayne, PA, USA) Standard AUTO12-A, Specimen Labels: Content and Location, Fonts, and Label Orientation.
The scientists have invented one high tech solution that they believe will bring their own error rate for mislabeled specimens to near zero and which, with further refinement, may become suitable for use on commercial automation systems. This is a robotic camera system that can lift a specimen tube from the transport carrier on an automated track, take four simultaneous photographs of the tube using four equidistantly spaced high resolution cameras, and precisely stitch the four photographs into a single photograph of the entire exterior of the tube. It then uses optical character recognition (OCR) to compare the patient name on the original label to the patient name in the laboratory information system (LIS), as identified by reading the barcode on the LIS label.
Since the robotic system was implemented in October 2012, the system has collected and analyzed some 2.4 million images and more than 300 mislabeled specimens have been detected, of which only 53% were found through our normal quality assurance processes. For the subset of specimens routed through this advanced automation, significantly fewer corrected reports have been issued.
Related Links:
College of American Pathologists
ARUP Laboratories
Clinical and Laboratory Standards Institute
The best data on errors in USA laboratories is derived from three separate College of American Pathologists (CAP; Northfield, IL, USA) Q-Probe studies, in which the reported rates of mislabeled specimens were 0.39/1,000 in 120 institutions in 2006, 0.92/1,000 in 147 clinical laboratories in 2008, and 1.12% of blood bank specimens in 122 clinical laboratories.
Laboratory scientists at the ARUP Laboratories (Salt Lake City, UT, USA) have examined the problem of misidentification and have suggested some possible solutions. One approach is the single piece flow and this concept has significant error-proofing potential for labeling tasks at relatively low cost. They suggest that to prevent errors during collection and processing, avoid having specimens from multiple patients in the active work area at the same time. Similarly, avoid using strips of labels from a label printer with labels for multiple patients that must be matched to specimens and if using an automated aliquoting device, be sure that the label exactly duplicates the barcode label from the primary tube to facilitate error detection.
Another tool that more laboratories are using is the portable barcode scanner. These scanners read wristband barcodes at point-of-collection and work well in conjunction with portable barcode label printers or point-of-care analytical devices. However, barcode devices make more errors than commonly believed. Display and layout inconsistency of the barcode can also leads to an increase in errors. It is recommended to implement the Clinical and Laboratory Standards Institute (Wayne, PA, USA) Standard AUTO12-A, Specimen Labels: Content and Location, Fonts, and Label Orientation.
The scientists have invented one high tech solution that they believe will bring their own error rate for mislabeled specimens to near zero and which, with further refinement, may become suitable for use on commercial automation systems. This is a robotic camera system that can lift a specimen tube from the transport carrier on an automated track, take four simultaneous photographs of the tube using four equidistantly spaced high resolution cameras, and precisely stitch the four photographs into a single photograph of the entire exterior of the tube. It then uses optical character recognition (OCR) to compare the patient name on the original label to the patient name in the laboratory information system (LIS), as identified by reading the barcode on the LIS label.
Since the robotic system was implemented in October 2012, the system has collected and analyzed some 2.4 million images and more than 300 mislabeled specimens have been detected, of which only 53% were found through our normal quality assurance processes. For the subset of specimens routed through this advanced automation, significantly fewer corrected reports have been issued.
Related Links:
College of American Pathologists
ARUP Laboratories
Clinical and Laboratory Standards Institute
Latest Hematology News
- New Guidelines Aim to Improve AL Amyloidosis Diagnosis
- Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
- Fast and Easy Test Could Revolutionize Blood Transfusions
- High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
- AI Algorithm Effectively Distinguishes Alpha Thalassemia Subtypes
- MRD Tests Could Predict Survival in Leukemia Patients
- Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
- Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
- ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
- Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage
- Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
- Platelets Could Improve Early and Minimally Invasive Detection of Cancer
- Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
- Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results
- First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes

- New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







